1)Lennon VA:Paraneoplastic autoantibodies:the case for a descriptive generic nomenclature. Neurology 44:2236-2240, 1994
2)Thirkill CE, Roth AM, Keltner JL:Cancer-associated retinopathy. Arch Ophthalmol 105:372-375, 1987
3)Adamus G, Guy J, Schmied JL et al:Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 34:2626-2633, 1993
4)To KW, Thirkill CE, Jakobiec FA et al:Lymphoma-associated retinopathy. Ophthalmology 109:2149-2153, 2002
5)Thirkill CE, Keltner JL, Tyler NK et al:Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 111:931-937, 1993
6)Ohguro H, Yokoi Y, Ohguro I et al:Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 137:1117-1119, 2004
7)山添健二・福島敦樹・上野脩幸:頭蓋内悪性リンパ腫にともなったCARの1例.眼臨紀 1:565-568,2008
8)Keltner JL, Thirkill CE, Tyler NK et al:Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110:48-53, 1992
9)Murphy MA, Thirkill CE, Hart WM Jr:Paraneoplastic retinopathy:a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol 17:77-83, 1997
10)Guy J, Aptsiauri N:Treatment of paraneoplastic visual loss of 3 cases. Arch Ophthalmol 117:471-477, 1999
11)高橋政代・平見恭彦・佐久間圭一朗・他:早急な治療により視力改善が得られた癌関連網膜症(CAR)の1例.日眼会誌 112:806-811,2008